Yersinia pestis infection cost-effectiveness of therapy

Jump to: navigation, search

Yersinia pestis infection Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Yersinia Pestis Infection from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

Treatment

Medical Therapy

Primary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Yersinia pestis infection cost-effectiveness of therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Yersinia pestis infection cost-effectiveness of therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Yersinia pestis infection cost-effectiveness of therapy

CDC on Yersinia pestis infection cost-effectiveness of therapy

Yersinia pestis infection cost-effectiveness of therapy in the news

Blogs on Yersinia pestis infection cost-effectiveness of therapy

Directions to Hospitals Treating Yersinia pestis infection

Risk calculators and risk factors for Yersinia pestis infection cost-effectiveness of therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: João André Alves Silva, M.D. [2]

Overview

Without treatment, the plague can cause serious illness or death. With adequate antibiotic treatment the mortality rate is about 8-10%.[1] Therefore the treatment of plague may be considered cost-effective.

References


Linked-in.jpg